James Cann is an experienced HTA and market access professional with a strong background in strategic communications and medical writing. They have worked in various roles, including Senior Manager at Regeneron and Freelance HTA/Market Access Specialist. James contributed to significant projects at organizations such as Heron Evidence Development and Amgen, where they developed HTA submissions and payer communication materials. With a BSc in Biomedical Sciences from UCL, they have built expertise across multiple therapy areas and notable experience in clinical audits and ethics review as a member of the Health Research Authority.
This person is not in the org chart
This person is not in any teams
This person is not in any offices